Artificial Intelligence in Early Diagnosis and Prevention of Oral Cancer
Overview
Authors
Affiliations
The global occurrence of oral cancer (OC) has increased in recent years. OC that is diagnosed in its advanced stages results in morbidity and mortality. The use of technology may be beneficial for early detection and diagnosis and thus help the clinician with better patient management. The advent of artificial intelligence (AI) has the potential to improve OC screening. AI can precisely analyze an enormous dataset from various imaging modalities and provide assistance in the field of oncology. This review focused on the applications of AI in the early diagnosis and prevention of OC. A literature search was conducted in the PubMed and Scopus databases using the search terminology "oral cancer" and "artificial intelligence." Further information regarding the topic was collected by scrutinizing the reference lists of selected articles. Based on the information obtained, this article reviews and discusses the applications and advantages of AI in OC screening, early diagnosis, disease prediction, treatment planning, and prognosis. Limitations and the future scope of AI in OC research are also highlighted.
Vinay V, Jodalli P, Chavan M, Buddhikot C, Luke A, Ingafou M Diagnostics (Basel). 2025; 15(3).
PMID: 39941210 PMC: 11816433. DOI: 10.3390/diagnostics15030280.
Current trends on prevalence, risk factors and prevention of oral cancer.
Coletta R, Yeudall W, Salo T Front Oral Health. 2024; 5:1505833.
PMID: 39606098 PMC: 11599248. DOI: 10.3389/froh.2024.1505833.
Kapoor D, Saini P, Sharma N, Singh A, Prajapati B, Elossaily G EXCLI J. 2024; 23:1091-1116.
PMID: 39391057 PMC: 11464865. DOI: 10.17179/excli2024-7253.
Epidemiology, Diagnostics, and Therapy of Oral Cancer-Update Review.
Kijowska J, Grzegorczyk J, Gliwa K, Jedras A, Sitarz M Cancers (Basel). 2024; 16(18).
PMID: 39335128 PMC: 11430737. DOI: 10.3390/cancers16183156.
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions.
Pham T, Teh M, Chatzopoulou D, Holmes S, Coulthard P Curr Oncol. 2024; 31(9):5255-5290.
PMID: 39330017 PMC: 11430806. DOI: 10.3390/curroncol31090389.